Navigation Links
Fat Kills Cancer: Turning Stem Cells from Fat Tissue into,Personalized, Cancer-Targeted Therapeutics

nsert the gene cytosine deaminase into the cell. This gene can convert a less toxic drug, 5-fluorocytosine (5-FC), to 5-FU inside the stem cells, and the chemotherapy can then seep out into the tumor, producing a lethal by-stander effect.

In nude mice – animals with an inhibited immune system – engrafted with human colon cancer, the researchers first injected the engineered mesenchymal stem cells, then 5-FC. They found tumor growth was inhibited by up to 68.5 percent in the animals, and none of the mice exhibited any signs of toxic side effects.

However, none of the animals remained tumor-free. “The procedure was quite effective even though we applied the stem cells just once. Obviously, repeated treatment will increase the efficacy, as would using this strategy in combination with other treatments,” Altaner said.

Normal mesenchymal cells can be isolated from various sources, including bone marrow, but the yield is not nearly as great as what the researchers derived from fat tissue. Removal of fat tissue during surgery to remove a tumor would be simple, says Altaner. Liposuction could also be used to isolate mesenchymal stem cells can also be gathered and isolated through liposuction, and the cells frozen in liquid nitrogen for future therapeutic use. Both processes would be easier than taking bone marrow from a patient, Altaner said.

The study was funded by grants from the Slovak Academy of Sciences and the League Against Cancer, and support from the Slovakian national cancer genomics program.

# # #

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes nearly 26,000 basic, translational, and clinical researchers; health care professionals; an
'"/>




Page: 1 2 3

Related medicine technology :

1. News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
2. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
5. In Vitro and In Vivo Data Show Alfacells Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells
6. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
7. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
8. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
9. Pluristems PLX Cells Demonstrate Potential to Treat Parkinsons Disease
10. Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetixs AAGP
11. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
Post Your Comments:
(Date:11/30/2008)... , CHICAGO, Dec. 1 O...cerebral blood flow and a greater number of small ...presented today at the annual meeting of the Radio... The study, conducted at the University of Nort... compare brain scans of older adults who exercise ...
(Date:11/28/2008)...APOLIS, Nov. 28 Eli Lill...pplemental New Drug Application (sNDA) from,the U...a(R) (duloxetine HCl),for the management of chron...n,the first half of 2009, adding data from a rece...hritis pain of the knee. , The decision doe...
(Date:11/26/2008)...sed information density, automation and intelligen...n ultrasound to an all new level , , CHICAG...s Healthcare ( www.siemens.com/healthcare ) hi...ume Scanner (ABVS)(1), the world,s first multi-us...he 94th Scientific Assembly and Annual Meeting of ...
(Date:11/25/2008)...ILLE, Ky., Nov. 25 Klei...eons performed the fifth U.S. hand transplant on M... Louisville,s Jewish Hospital Hand Care Center on ...an around noon and was completed shortly after 9 p...ttp://www.newscom.com/cgi-bin/prnh/20081125/DC4855...
Breaking Medicine Technology:Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3VIE Healthcare Expands Its Operations in the Midwest and Obtains First Local Client 14637 1VIE Healthcare Expands Its Operations in the Midwest and Obtains First Local Client 14637 2CVS Caremark Corp to Pay 2436 7 Million to U S 23 States 26 D C to Settle Medicaid Prescription Drug Fraud Allegations 14636 1CVS Caremark Corp to Pay 2436 7 Million to U S 23 States 26 D C to Settle Medicaid Prescription Drug Fraud Allegations 14636 2AUDIO from Medialink and Kelloggs 3A A Blissful Way to Recommit to Your Resolution 14634 1New Foam Treatment for Varicose Veins 14633 1New Foam Treatment for Varicose Veins 14633 2
...re/ -- Accera, Inc.,today is presenting data from ...trial of AC-1202 (Ketasyn) in Alzheimer,s disease ...l Conference on,Prevention of Dementia in Washingt...linical and preclinical studies, AC-1202 was,shown...y and,cognition of subjects of a particular pharma...
...2007 - Critical,Therapeutics, Inc. (Nasdaq: CRTX) ...otal Phase III clinical trial of ZYFLO CR(TM),(zil...ssue of the,Journal of Asthma. ZYFLO CR was approv...on May 30, 2007. Critical Therapeutics,together w...cts to,begin marketing ZYFLO CR in the U.S. in the...
Other Medicine Technology:Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 2Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 3Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 2Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 3Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 5
(Date:12/2/2008)... Trials of tasimelteon show it could aid shift wo...ESDAY, Dec. 2 (HealthDay News) -- The experimental...aused by jet lag or night shifts, according to the...e II study included 39 people randomly assigned to... mg of tasimelteon, or a placebo. They were monito...
(Date:12/2/2008)... ORLANDO, Fla., Dec. 2 MEDai, Inc...care solutions provider, has added a new module,t...ons. The new stand-alone,module monitors a popul...delines and alerts stakeholders when there has bee...e Risk Navigator Guidelines(TM) provides,real-tim...
(Date:12/2/2008)... -Survey Reveals Nearly Half Have Skipped Medical...., Dec. 2 A new survey ...urce Center (NWHRC) highlights another troubling a...have failed to seek health care for themselves or ...ate that many women say their health has gotten wo...
(Date:12/2/2008)... MALVERN, Pa., Dec. 2 Arlington M...ket intelligence for the pharmaceutical and diagno...Janssen Pharmaceuticals, Levaquin,is the preferre... general,medical-surgical hospitals in the United...lung, sinus, skin and urinary tract infections cau...
Breaking Medicine News(10 mins):Health News:Drug Effective for Temporary Sleep Disruptions 2Health News:MEDai Evidence-Based Guideline Reporting Provides Decision Support at Point of Care 2Health News:Rising Health Costs Prompt Women to Neglect Health 2Health News:Rising Health Costs Prompt Women to Neglect Health 3Health News:Rising Health Costs Prompt Women to Neglect Health 4Health News:Levaquin is the Preferred Quinolone Among More Than Half of All General Medical-Surgical Hospitals in the United States 2
... Holtgrave, PhD, an expert on HIV prevention at th... a targeted campaign of testing and counseling aim... more effective than the mass patient screening pr...rol and Prevention (CDC). Holtgraves study is the...
...issue of CHEST, reports that children receiving an...r risk for developing asthma by age 7 than those ...oubled in children receiving antibiotics for nonre...ldren who received multiple antibiotic courses and...
... the issue of Neurology, the scientific journal of...easily distressed and have more negative emotions ...ore easygoing people. In the study, those who mos...ch as depression and anxiety were 40 percent more ...
...es re-sat their examinations Monday after a cheati...lts, an official said Monday . Lawyers hired by th...hools (CGFNS) acted as observers at examination ce...vao. Labour Secretary Arturo Brion said the gradu...
Other Medicine News:Health News:Targeted HIV Testing An Effective Way to Screen HIV Patients 2Health News:Antibiotic Use in Infants may Lead to Asthma. 2Health News:Pessimists may Develop More Memory Problems 2Health News:Philippine Nurses Re-sit Scandal-tainted Exams 2
Cold light source single outlet.
Cold light source triple outlet.
Cold light source single outlet.
The 9100 is a truly affordable 100 Watt xenon light source providing accurate color and brightness. This xenon light source is ideal for surgery centers, evaluations or general office use.
Medicine Products: